emodin and paclitaxel
emodin has been researched along with paclitaxel in 13 studies
Research
Studies (13)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fang, X; Shao, L; Wang, S; Zhang, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Bai, Z; Shao, J; Wang, C; Wang, W; Yuan, Y; Zhang, F | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fan, L; Hao, X; Hu, X; Shao, J; Wang, J; Wang, W; Yuan, Y; Zhao, W; Zheng, Y; Zhu, L; Zhu, Y | 1 |
| Hortobagyi, GN; Hung, MC; Lau, YK; Xia, W; Zhang, L | 1 |
| Li, J; Liu, P; Mao, H; Wanga, A; Zhang, X | 1 |
| Guo, H; Sun, D; Xiang, Z; Zhang, Y | 1 |
| Chen, S; Zhang, J; Zhang, Z | 1 |
| He, X; Hu, B; Lin, H; Mao, J; Peng, Y; Wang, J; Wang, Y; Zhang, F; Zhang, T; Zheng, J | 1 |
| Cui, W; He, Y; Li, X; Wei, L; Zhang, J; Zhang, S | 1 |
| Liu, XX; Tan, S; Tang, L; Yang, XD; Zou, ZW | 1 |
Other Studies
13 other study(ies) available for emodin and paclitaxel
| Article | Year |
|---|---|
CHMIS-C: a comprehensive herbal medicine information system for cancer.
Topics: Antineoplastic Agents, Phytogenic; Databases, Factual; Internet; National Institutes of Health (U.S.); Neoplasms; Phytotherapy; Plant Preparations; United States; United States Food and Drug Administration | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Synthesis and antitumor activity of emodin quaternary ammonium salt derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Emodin; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Molecular Structure; Quaternary Ammonium Compounds; Salts; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cations; Cell Line, Tumor; Emodin; Humans; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Division; Disease Models, Animal; Drug Synergism; Emodin; Enzyme Inhibitors; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Receptor, ErbB-2; Tumor Cells, Cultured; Tyrosine | 1999 |
Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Emodin; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Ovarian Neoplasms; Paclitaxel; RNA, Messenger; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2009 |
Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Chemotherapy, Adjuvant; Emodin; Female; Gene Expression; Humans; Mice, SCID; Paclitaxel; Phosphogluconate Dehydrogenase; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Emodin; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Paclitaxel; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Movement; Cell Survival; Cytochrome P-450 CYP1B1; Drug Resistance, Neoplasm; Emodin; Humans; Lung Neoplasms; MAP Kinase Signaling System; Molecular Docking Simulation; Molecular Structure; Paclitaxel; Proteins; Proto-Oncogene Proteins c-akt | 2020 |
Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Emodin; Female; Glucosides; Humans; Ovarian Neoplasms; Paclitaxel; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2021 |
A compound formulation of EGF-modified paclitaxel micelles and EGF-modified emodin micelles enhance the therapeutic effect of ovarian cancer.
Topics: Cell Line, Tumor; Emodin; Epidermal Growth Factor; Female; Humans; Liposomes; Micelles; Ovarian Neoplasms; Paclitaxel | 2023 |